Safety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicity.

Source:http://linkedlifedata.com/resource/pubmed/id/20166241

Download in:

View as

General Info

PMID
20166241